Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of TB006 in Participants With Alzheimer’s Disease
Condition(s):Alzheimer’s DiseaseLast Updated:November 18, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Alzheimer’s DiseaseLast Updated:November 18, 2023Completed
Condition(s):Colorectal Cancer; Bowel IleusLast Updated:September 2, 2021Unknown status
Condition(s):Hairy Cell Leukemia; Hairy Cell Leukemia VariantLast Updated:March 22, 2024Recruiting
Condition(s):Healthy SubjectsLast Updated:January 31, 2023Recruiting
Condition(s):Acute Coronary SyndromeLast Updated:November 3, 2023Completed
Condition(s):Acute Coronary SyndromeLast Updated:November 1, 2021Completed
Condition(s):GBM; DepressionLast Updated:December 7, 2015Unknown status
Condition(s):Healthy Subjects; PK/PDLast Updated:September 19, 2019Completed
Condition(s):Coronary Artery Disease; Percutaneous Coronary Intervention; Platelet Aggregation InhibitorsLast Updated:September 23, 2019Completed
Condition(s):Still’s Disease, Adult-OnsetLast Updated:December 6, 2016Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.